Options for Stage II Melanoma: Making the Decision That’s Right For You
A Resource for Melanoma Nurses: Understanding Stage II Melanoma
As melanoma nurses, you play a crucial role in supporting patients through their diagnosis and treatment journey. For patients diagnosed with Stage II melanoma—a deeper melanoma that may or may not be ulcerated and does not involve the lymph nodes—it’s important to provide clear and compassionate information about their treatment options.
After surgical removal of Stage II melanoma, there are typically two paths to consider:
- Active Surveillance: This approach involves closely monitoring the patient for any signs of recurrence without administering further treatment. It allows for quick intervention if any changes are detected.
- Adjuvant Therapy: In some cases, your healthcare provider may recommend adjuvant therapy following surgery. This treatment aims to reduce the risk of melanoma returning or spreading.
To aid you in discussing these options with your patients, we have prepared a Q&A featuring insights from two medical experts.
Expert Insights:
Dr. Geoffrey Lim, a dermatologic surgeon at SkinMed Institute in Lone Tree, Colorado, has interviewed Dr. Jason Luke, Associate Professor of Medicine at the University of Pittsburgh Medical Center. Dr. Luke is a leading medical oncologist who has contributed significantly to adjuvant therapy research.
In this Q&A, they address key questions, including:
- Who is eligible for adjuvant therapy among Stage II melanoma patients?
- What are the pros and cons of adjuvant therapy versus active surveillance?
Feel free to share this resource with your patients to help them understand their options and empower them to engage in informed discussions with their healthcare team. Your support is vital in helping them navigate their treatment journey with confidence.